United Kingdom · Seed startup

Who invested in Re-Aim Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$9.4Mraised across 1 round since 2026, from 1 source

Latest round
Seed, $9.4MMay 2026
Investors
1
See who backed them

The rounds

  1. May 2026
    Seed$9.4M

    Source recorded

Everyone who backed them

Oxford Science EnterprisesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Re-Aim Therapeutics

Who invested in Re-Aim Therapeutics?

Re-Aim Therapeutics's investors include Oxford Science Enterprises.

How much has Re-Aim Therapeutics raised?

Re-Aim Therapeutics has raised $9.4M across 1 round since 2026.

When did Re-Aim Therapeutics last raise?

Re-Aim Therapeutics's most recent round was a Seed of $9.4M in May 2026.

What was Re-Aim Therapeutics's biggest round?

Its most recent round, $9.4M in May 2026, is also its largest on record.

Who backed Re-Aim Therapeutics first?

Re-Aim Therapeutics's first round on record, in May 2026, was backed by Oxford Science Enterprises.

What stage is Re-Aim Therapeutics at?

Re-Aim Therapeutics's latest named round is a Seed, in May 2026.

Where is Re-Aim Therapeutics based?

Re-Aim Therapeutics is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app